GSK taps UK firm for 'beyond antibodies' drug technology
LONDON (Reuters) - GlaxoSmithKline plans to exploit new technology from private British biotech company Immunocore to develop next-generation drugs ag...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/jqeaJ6MDS8o/story01.htm
No comments:
Post a Comment